Enterprise Value

0.00

Cash

172.4M

Avg Qtr Burn

N/A

Short % of Float

11.89%

Insider Ownership

1.31%

Institutional Own.

36.82%

Qtr Updated

09/30/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
SP-102 (SEMDEXA™) Details
Sciatica , Spine disorder

NDA

FDA meeting

Phase 3

Data readout

Phase 3

Initiation

COVI-MSC (STI-8282) (CoronaStem1) Details
ARDS (Acute respiratory distress syndrome) associated with COVID-19

Phase 2

Data readout

SP-103 Details
Acute Low Back Pain

Phase 2

Data readout

Phase 2

Data readout

Phase 1

Data readout

Failed

Discontinued

Failed

Discontinued

Abivertinib Maleate (Fujovee) (STI-5656) (BTK inhibitor) Details
Solid tumor/s, Cancer, Prostate cancer, Castration-resistant prostate cancer

Failed

Discontinued

Failed

Discontinued

STI-2020 (COVI-AMG) Details
COVID-19, Solid tumor/s

Failed

Discontinued